Dr. Giovanni Tosi was born on 1977. Since 15th November 2005, is researcher in the scientific field of Pharmaceutical Technology at the University of Modena and Reggio Emilia. Actually is confirmed researcher, at the department of Pharmaceutical Sciences and belongs to the faculty of Pharmacy.
The research activity is based on the development of lipid and polymeric systems for the delivery and the targeting of drugs to diseased tissues or cells. In particular, the fields of research could be summarized as follows:
Drug delivery to the Central Nervous System, by using nanoparticulate vectors in particular, the research is focus on the planning, preparation, characterization and administration of Np after surface modifications. By applying in vivo pharmacological tests, personally performed by dr. Tosi, several interesting results have been reached, confirming the high potential of these systems. In particular, the Np, loaded with selected drugs or labeled with fluorescent dyes, were found to be able to cross the Blood-brain barrier, opening the study to the possibility of a non-invasive treatment of cerebral pathologies. At the same time, considering the guidelines of the European Community and FDA, a number of studies on the biodistribution of these vectors, by using fluorescent dye and HPLC/fluorimetric methodologies.
1. How many years have you been practicing and/or performing research?
I was involved in research since 2000, it is almost 15 years of driving research.
2. What is the research topic you are working on now?
My topics are mainly based on nanomedicine for innovative treatment in Central Nervous System and tumor. Nanotechnology applied to medicine.
3. What makes an article top quality?
Top quality articles are constituted by different skilled researcher in many fields, with competences in complementary topics, all sharing the same objective.
4. What are the qualities you look for in an article?
b. Methods and protocol reproducibile
c. Clear results and clear discussion
d. Absence of not proven hypothesis.
5. Do you have any research funding (NIH or other national funding) now?
Yes, Grant from Neurodegenerative associations and Italian Grants.
6. When did you become an editor of OMICS Journal?
7. What is your greatest career accomplishment?
Hot topic issue in Society for Neurosciene world meeting for 2012 and 2013.
8. How does the research published percolate through to practitioners?
This is the most important topic: how to translate research findings to application. This is only possible by producing results, reproducible and innovative, with great level of interdisciplinarity and with good perspective to Industrial field for scale up processes.
9. What is the purpose of serving as an editor?
To select only high papers.
10. Do you have any patents?
Yes, a couple.
11. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?
12. Do you plan to contribute any editorials or papers to OMICS Journals in the next year?
13. Do you have any trouble with OMICS Journals in the past?
14. Would you recommend OMICS to your friends or colleagues?
15. How do you differentiate Pharmaceutica Analytica Acta with other journals in the field?
To organize sections for specific pathology and innovation in treatments, at the cutting edge of technology.